JPS6479155A - Diphenylpyridine compound - Google Patents

Diphenylpyridine compound

Info

Publication number
JPS6479155A
JPS6479155A JP63144192A JP14419288A JPS6479155A JP S6479155 A JPS6479155 A JP S6479155A JP 63144192 A JP63144192 A JP 63144192A JP 14419288 A JP14419288 A JP 14419288A JP S6479155 A JPS6479155 A JP S6479155A
Authority
JP
Japan
Prior art keywords
compound
formula
lower alkyl
diphenylpyridine
formula iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63144192A
Other languages
Japanese (ja)
Inventor
Hisashi Takasugi
Atsushi Kuno
Hiroyoshi Sakai
Yoshie Sakamoto
Takao Takadai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP63144192A priority Critical patent/JPS6479155A/en
Priority claimed from HU885132A external-priority patent/HUT51614A/en
Publication of JPS6479155A publication Critical patent/JPS6479155A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:The diphenylpyridine compound of formula I (R<1> is lower alkylcarbamoyl substituted with heterocyclic group; R<2> is nitro; R<3> is lower alkyl, lower alkoxy or halogen; R<4> is lower alkyl) and its salt. EXAMPLE:2-Methyl-3-(2-morpholinoethylcarbamoyl)-4-(3-nitrophenyl)-6-ph enylpyri dine. USE:Useful as a remedy for ischemic diseases. It can be administered orally or parenterally. PREPARATION:The compound of formula I can be produced e.g. by reacting a compound of formula II (R<3>a is H, lower alkyl, lower alkoxy or halogen) with a compound of formula III or its salt. The starting compounds of formula II and formula III are novel and the compound of formula III can be synthesized by using a compound of formula IV and a compound of formula V as starting raw materials. The compound of formula II is derived from the compound of formula VI and the compound of formula III.
JP63144192A 1987-06-11 1988-06-10 Diphenylpyridine compound Pending JPS6479155A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63144192A JPS6479155A (en) 1987-06-11 1988-06-10 Diphenylpyridine compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14599687 1987-06-11
JP63144192A JPS6479155A (en) 1987-06-11 1988-06-10 Diphenylpyridine compound
HU885132A HUT51614A (en) 1985-12-12 1988-10-04 Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents

Publications (1)

Publication Number Publication Date
JPS6479155A true JPS6479155A (en) 1989-03-24

Family

ID=27270049

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63144192A Pending JPS6479155A (en) 1987-06-11 1988-06-10 Diphenylpyridine compound

Country Status (1)

Country Link
JP (1) JPS6479155A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360472A (en) * 1992-12-17 1994-11-01 Xerox Corporation Waterfast dye compositions
WO1994027604A1 (en) * 1993-05-28 1994-12-08 Taisho Pharmaceutical Co., Ltd. Medicinal use of pyridine derivative
US6384058B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof
US6503917B1 (en) 1998-12-10 2003-01-07 Wyeth, Five Giralda Farms 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360472A (en) * 1992-12-17 1994-11-01 Xerox Corporation Waterfast dye compositions
WO1994027604A1 (en) * 1993-05-28 1994-12-08 Taisho Pharmaceutical Co., Ltd. Medicinal use of pyridine derivative
US6384058B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof
US6384057B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis
US6384060B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
US6503917B1 (en) 1998-12-10 2003-01-07 Wyeth, Five Giralda Farms 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof

Similar Documents

Publication Publication Date Title
EP0283970A3 (en) New peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same
DE3888756T2 (en) Carbamoylpyrrolidone derivatives, their use and preparation.
DK0615549T3 (en) Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds with a yeast reductase
ES8704445A1 (en) Phenylisopropylamine derivative and its preparation.
ES8307792A1 (en) Dihydropyridine compounds.
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
JPS6479155A (en) Diphenylpyridine compound
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
JPS5916871A (en) Sulfonamide-based benzamides
ES8103067A1 (en) Phenyliminothiazoline derivatives, their preparation and intermediates therefor, pharmaceutical preparations containing them and their production.
PT86653A (en) PROCESS FOR THE PREPARATION OF NOVEL CRYSTALLINE CEFADROXIL COMPOUNDS AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
KR840005449A (en) Benzothiopyranopyridinone
ES2013322A6 (en) Derivatives of 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonines and -1,4-benzoxazonines, processes for their production and their use as pharmaceuticals
ES8106703A1 (en) Intermediate and process for the preparation of 7-acylindolin-2-ones
KR840007420A (en) Method for preparing substituted carboxy-thiazolo [3,2-α] pyrimidine derivatives
IE882107L (en) Pyrimidones
ES2001804A6 (en) Process for the preparation of ranitidine or acid addition salts thereof, and intermediates for this preparation.
SU607548A3 (en) Method of obtaining formamidine derivatives
US4202977A (en) S-Triazolo [1,5-a] pyridine derivatives
ES2004991A6 (en) Production of quinazolinone derivative
EP0230018A3 (en) Pyrethroide, process for their preparation and their use in combatting parasites as well as precursors for the preparation of these pyrethroids
DK0492350T3 (en) Process for Preparation of (S) -vinyl- and (S) -allenyl-GABA
JPS5690067A (en) Novel heterocyclic ring substituted phenylacetic acid derivative
DE3483011D1 (en) SUBSTITUTED ALKYLAMINO DERIVATIVES OF 6,11-DIHYDRO-11-OXO-DIBENZ (B, E) -OXEPIN, PROCESS FOR THE PRODUCTION THEREOF, THEIR INTERMEDIATE PRODUCTS AND THEIR USE AS A MEDICINAL PRODUCT.
GB1469410A (en) Benzodioxole derivatives